Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000950170-24-109410

President and CEO sold 11,747 shares at an average $24.11 ($283,223)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Harris Todd · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-23 Sale : show line 1 in the form 10b5-1 −10,092 $24.13 $243,477 1,479,528 D
2024-09-24 Sale : show line 2 in the form 10b5-1 −1,055 $24.02 $25,341 1,478,473 D
2024-09-25 Sale : show line 3 in the form 10b5-1 −600 $24.01 $14,406 1,477,873 D
Open-market sales · 11,747 sh · avg $24.11 · $283,223
Loading xslF345X05/ownership.xml…